Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes

<p>Table S1. Genes included in the targeted DNA panel sequencing. Table S2. Differences in clinical characteristics by molecular subtype. Table S3. Distributions of mutation status in PBRM1 and SETD2 by molecular subtype in RNASeq and Nanostring datasets. Table S4. Differentially expressed gen...

Saved in:

書目詳細資料
主要作者:	Jiwei Bai (15051797) (author)
其他作者:	Jianxin Shi (15051800) (author), Yazhuo Zhang (15051803) (author), Chuzhong Li (15051806) (author), Yujia Xiong (15051809) (author), Hela Koka (15051812) (author), Difei Wang (15051815) (author), Tongwu Zhang (15051818) (author), Lei Song (15051821) (author), Wen Luo (15051824) (author), Bin Zhu (15051827) (author), Belynda Hicks (15051830) (author), Amy Hutchinson (15051833) (author), Erin Kirk (15051836) (author), Melissa A. Troester (15051839) (author), Mingxuan Li (15051842) (author), Yutao Shen (15051845) (author), Tianshun Ma (15051848) (author), Junmei Wang (15051851) (author), Xing Liu (15051854) (author), Shuai Wang (15051857) (author), Songbai Gui (15051860) (author), Mary L. McMaster (15051863) (author), Stephen J. Chanock (15051866) (author), Dilys M. Parry (15051869) (author), Alisa M. Goldstein (15051872) (author), Xiaohong R. Yang (15051875) (author)
出版:	2025
主題:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Genome Biology Comparative transcriptomics Rare Cancers Translational Research
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Table S2 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
由: Junfeng Xu (16437141)
出版: (2025)

Table S3 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
由: Junfeng Xu (16437141)
出版: (2025)

العمل بالأكثر والغالب عند الأصوليين: دراسة تطبيقية
由: Al-mutiri, Aloush Khaled
出版: (2022)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
由: Zhongyi Zhang (219440)
出版: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
由: Zhongyi Zhang (219440)
出版: (2025)

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
由: Alyssa C. Flint (16676029)
出版: (2025)

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
由: Alyssa C. Flint (16676029)
出版: (2025)

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
由: Gwo Yaw Ho (14961416)
出版: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
由: Evangeline R. Jackson (15558808)
出版: (2025)

Spreadsheet index of named bookbinders in the Sotheby's auction catalogues for the sales of the Major John Roland Abbey collection, sold between 1965 and 1989
由: John Hodgson (22668215)
出版: (2025)

Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
由: Dipika R. Mohan (15011204)
出版: (2025)

Supplementary Tables from Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer
由: Yemin Wang (17315078)
出版: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
由: Shasha Wei (1555588)
出版: (2025)

Supplementary Table S10 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
由: Anfal Alsadhan (15907475)
出版: (2025)

Supplementary Table S4 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
由: Anfal Alsadhan (15907475)
出版: (2025)

Supplementary Table S5 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
由: Anfal Alsadhan (15907475)
出版: (2025)

Supplementary Table S6 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
由: Anfal Alsadhan (15907475)
出版: (2025)

Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
由: Anfal Alsadhan (15907475)
出版: (2025)

Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
由: Anfal Alsadhan (15907475)
出版: (2025)

Supplementary Table S9 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
由: Anfal Alsadhan (15907475)
出版: (2025)

Additional file 1 of Combined metabolome and transcriptome profiling provides insights into dynamic molecular control of lemon (Citrus Limon L.) peel development
由: Hongming Liu (631933)
出版: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
由: Francesca Orzan (15055579)
出版: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
由: Francesca Orzan (15055579)
出版: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
由: Francesca Orzan (15055579)
出版: (2025)

Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
由: Justin Hwang (15925675)
出版: (2025)

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
由: Justin Hwang (15925675)
出版: (2025)

Supplementary Figure 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
由: Justin Hwang (15925675)
出版: (2025)

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
由: Justin Hwang (15925675)
出版: (2025)

Supplementary Table 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
由: Justin Hwang (15925675)
出版: (2025)

Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
由: Justin Hwang (15925675)
出版: (2025)

Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf
由: Bin Tang (56654)
出版: (2025)

Supplementary Table S1 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
由: Nadia Mezghani (15055724)
出版: (2025)

Supplementary Table S3 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
由: Nadia Mezghani (15055724)
出版: (2025)

Supplementary Table S4 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
由: Nadia Mezghani (15055724)
出版: (2025)

Data Sheet 1_Response mechanisms of Polygonatum kingianum to temperature stress: implications for cultivation practices.pdf
由: Huali Qian (11711225)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_jpqajeru6vcaclqtirou57ndlq